Mutant CDKN2A regulates P16/p14 expression by alternative splicing in renal cell carcinoma metastasis

Sun, QR; Chen, SY; Hou, YJ; Wen, XD; Teng, XD; Zhang, HH; Lai, C; Lai, MD

Lai, MD (corresponding author), China Pharmaceut Univ, Sch Basic Med & Clin Pharm, Dept Basic Med, Nanjing 211198, Peoples R China.

PATHOLOGY RESEARCH AND PRACTICE, 2021; 223 ():

Abstract

Objective: Metastatic renal cell carcinoma (mRCC) is the important factor for patient mortality, meanwhile gene mutation constantly changes cancer pro......

Full Text Link